Goldenseal
Scientific Name(s): Hydrastis canadensis L. Family: Ranunculaceae (buttercups)
Common Name(s): Goldenseal , yellowroot , orangeroot , eyebalm , eyeroot , goldenroot , ground raspberry , Indian turmeric , yellow puccoon , jaundice root , sceau d'or
Clinical Overview
![]() |
Uses of Goldenseal
Goldenseal may be of use in topical infections and is used as an eyewash. Goldenseal has been included in cold and flu preparations for its anticatarrhal effects but little evidence supports this use and its effects are debatable. Goldenseal may be of use in topical infections and is used as an eyewash.
Goldenseal Dosing
Extracts standardized to 5% hydrastine are available; however, the berberine content may be more important for goldenseal's medicinal uses. Doses of 100 mg hydrastine and 2 g crude root have been proposed.
Contraindications
Goldenseal is contraindicated in patients who have hypertension.
Pregnancy/Lactation
Documented uterine stimulant. Avoid use.
Goldenseal Interactions
Based on available data, goldenseal does not appear to interact with indinavir.
Goldenseal Adverse Reactions
Adverse effects to usual doses are rare. Very high doses of goldenseal may rarely induce nausea, anxiety, depression, seizures, or paralysis.
Toxicology
Research reveals little or no information regarding toxicology with the use of this product.
Botany
Goldenseal is a perennial herb found in the rich woods of the Ohio River valley and other locations in the northeastern US. The single, green-white flower, which has no petals, appears in the spring on a hairy stem above a basal leaf and 2 palmate, wrinkled leaves. The flower develops into a red seeded berry. The plant grows from horizontal, bright yellow rhizomes, which have a twisted, knotty appearance.
History
Goldenseal root was used medicinally by American Indians of the Cherokee, Catawba, Iroquois, and Kickapoo tribes as an insect repellent, a diuretic, a stimulant, and a wash for sore or inflamed eyes. 1 It was used to treat arrow wounds and ulcers, 2 as well as to produce a yellow dye. Early settlers learned of these uses from the Indians and the root found its way into most 19th century pharmacopeias. The Eclectic medical movement was particularly enthusiastic in its adoption of goldenseal for gonorrhea and urinary tract infections. The widespread harvesting of Hydrastis in the 19th century, coupled with loss of habitat, resulted in depletion of wild populations. In 1997, Hydrastis was listed under Appendix ΙΙ of the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES), which controls exports of the root to other countries. The final listing included roots or live plants but excluded finished products. As an alternative to wild harvesting, goldenseal was cultivated in the Skagit Valley of Washington state and is being promoted as a cash crop in New York, North Carolina, 3 and Canada. Because of its high price, goldenseal, like other expensive herbs, has often been adulterated. Common adulterants include species of Coptis and Xanthorrhiza , 4 both of which also contain large amounts of the yellow alkaloid berberine. The popular notion that goldenseal can be used to affect the outcome of urinalysis for illicit drugs evolved from the novel Stringtown on the Pike by pharmacist John Uri Lloyd, in which goldenseal bitters are mistaken for strychnine in a simple alkaloid test by an expert witness in a murder trial. 5 Goldenseal can be variously ingested prior to testing or added to the urine sample after collection. It is one of several adulterants commonly detected in urinalysis samples. 6
Chemistry
The isoquinoline alkaloids hydrastine (4%), berberine (up to 6%), and canadine are present in goldenseal root and are viewed as the principle bioactive components. 7 Other minor alkaloids such as canadaline 8 and canadinic acid 9 have been isolated. Quinic acid esters were elucidated. 10 Quantitation of the alkaloids has been accomplished in a variety of ways including spectrophotometry, 11 thin-layer chromatography, 12 ion-pair dye colorimetry, 13 high-performance liquid chromatography (HPLC), 14 capillary electrophoresis, 15 and CE-mass spectrometry. 16
Goldenseal Uses and Pharmacology
While berberine is widely distributed in plants, hydrastine is characteristic of goldenseal root and is considered to be the most important bioactive alkaloid. There is extensive pharmacologic literature on hydrastine and berberine. The alkaloids are poorly absorbed when taken orally, so studies of parenterally administered goldenseal alkaloids must be interpreted with care.
Antimicrobial activityAnimal data
Research reveals no animal data regarding the use of goldenseal for antimicrobial activity.
Clinical dataGoldenseal alkaloids have modest antimicrobial activity, which may be relevant when applied topically. Berberine, canadine, and canadaline had disinfectant activity against 6 strains of bacteria, while hydrastine was inactive. 17 Berberine sulfate was bactericidal against Vibrio cholerae but bacteriostatic to Staphylococcus aureus . 18 Berberine sulfate has been shown to block adherence of Streptococcus pyogenes to epithelial cells, which may be a reasonable mode of action for topical antimicrobial use. 19 Berberine has been identified as the active component of Hydrastis in an antitubercular assay, 10 while hydrastine and other isolated compounds had no activity.
Other usesBerberine has been reported to inhibit uptake of glucose by cancer cells, 20 and to inhibit tumor promotion by phorbol esters in a mouse skin carcinogenesis model. 21 Berberine showed weak activity in an antioxidant model. 22 Palmery investigated the inhibitory activity of Hydrastis alkaloids on isolated rabbit aorta stimulated by epinephrine, finding a weak synergistic effect for berberine, canadine, and canadaline, but no activity in hydrastine. 23 In isolated guinea pig ileum preparations, the same group found that berberine, canadine, and canadaline evoked contractions, while hydrastine again was inactive. 24 A third study found a relaxant effect of berberine on rabbit prostate strips stimulated by norepinephrine or phenylephrine; 25 however, an adrenergic mechanism was considered unlikely. While hydrastine is closely related to the convulsant isoquinoline alkaloid bicuculline, hydrastine had no activity in a GABA-receptor binding assay at high concentrations. 26
Dosage
Goldenseal has not been the subject of any formal clinical trials for external antiseptic or antiherpes properties. Extracts standardized to 5% hydrastine are available; however, the berberine content may be more important for goldenseal's medicinal uses. Doses of 100 mg hydrastine and 2 g crude root have been proposed. 27
Pregnancy/Lactation
Documented uterine stimulant. Avoid use. 28 , 29 , 30
Interactions
Based on available data, goldenseal does not appear to interact with indinavir. In 10 healthy subjects, pretreatment with 1140 mg of goldenseal root twice daily for 14 days did not alter the peak plasma concentration, oral clearance, half-life, or time to reach the peak concentration of indinavir when administered as a single oral dose of 800 mg. 31
Adverse Reactions
Very high doses of goldenseal may rarely induce nausea, anxiety, depression, seizures, or paralysis. Hydrastine was once used as a uterine hemostatic, 7 but was found inferior to ergot in the treatment of postpartum hemorrhage. Goldenseal is generally contraindicated for use in pregnancy. Because of hypertensive actions of the alkaloids, it is also contraindicated in cardiovascular patients.
Toxicology
Research reveals little or no information regarding toxicology with the use of this product.
Bibliography
1. Hobbs C. Goldenseal in early American medical botany. Pharmacy in History . 1990;32:79.2. Bolyard J. Medicinal Plants and Home Remedies of Appalachia . Springfield, IL: Charles C. Thomas,1981.
3. Davis J. Advances in goldenseal cultivation . North Carolina Cooperative Extension Service, Horticultural Information Leaflet No. 131, 1996.
4. Blaque G, et al. Les falsifications actuelles de l' “Hydrastis canadensis.” Bull Sci Phar . 1926;33:375.
5. Foster S. Goldenseal. Hydrastis canadensis. Botanical Series , No. 309, 2nd ed. Austin, TX: American Botanical Council, 1996.
6. Mikkelsen S, et al. Adulterants causing false negatives in illicit drug testing. Clin Chem . 1988;34:2333-36.
7. Genest K. Natural products in Canadian pharmaceuticals. ΙV. Hydrastis canadensis. Can J Pharm Sci . 1969;4:41-45.
8. Gleye J, et al. La canadine: nouvel alcloide d'Hydrastis canadensis. Phytochemistry . 1974;13:675-76.
9. Galeffi C, et al. Canadinic acid: An alkaloid from Hydrastis canadensis. Planta Med . 1997;63:194.
10. Gentry E, et al. Antitubercular natural products: berberine from the roots of commercial Hydrastis canadensis powder. Isolation of inactive 8-oxotetrahydrothalifendine, canadine, beta-hydrastine, and two new quinic acid esters, hycandinic acid esters-1 and -2. J Nat Prod . 1998;61:1187-93.
11. Caille G, et al. Dosage spectrophotofluormetrique des alcaloides berberine, tetrahydroberberine, hydrastine et application a l'extrait sec et a la teinture d'Hydrastis canadensis L. Can J Pharm Sci . 1970;5:55.
12. Datta D, et al. Thin layer chromatography and UV spectrophotometry of alcoholic extracts of Hydrastis canadensis. Planta Med . 1971;19:258-63.
13. El-Masry S, et al. Colorimetric and spectrophotometric determinations of hydrastis alkaloids in pharmaceutical preparations. J Pharm Sci . 1980;69:597-98.
14. Leone M, et al. HPLC determination of the major alkaloids extracted from Hydrastis canadensis L. Phytother Res . 1996;10:S45-46.
15. Unger M, et al. Improved detection of alkaloids in crude extracts applying capillary electrophoresis with field amplified sample injection. J Chromatogr A . 1997;791:323-331.
16. Sturm S, et al. Analysis of isoquinoline alkaloids in medicinal plants by capillary electrophoresis-mass spectrometry. Electrophoresis . 1998;19:3026-32.
17. Scazzocchio F, et al. Antimicrobial activity of Hydrastis canadensis extract and its major isolated alkaloids. Fitoterapia . 1998;64:58.
18. Amin A, et al. Berberine sulfate: antimicrobial activity, bioassay, and mode of action. Can J Microbiol . 1969;15:1067-76.
19. Sun D, et al. Berberine sulfate blocks adherence of Streptococcus pyogenes to epithelial cells, fibronectin, and hexadecane. Antimicrobial Agents Chemother 1988;32:1370-74.
20. Creasey W. Biochemical effects of berberine. Biochem Pharmacol . 1979;28:1081-84.
21. Nishino H, et al. Berberine sulfate inhibits tumor-promoting activity of teleocidin in two-stage carcinogenesis on mouse skin. Oncology . 1986;43:131-34.
22. Misík V, et al. Lipoxygenase inhibition and antioxidant properties of protoberberine and aporphine alkaloids isolated from Mahonia aquifolium. Planta Med . 1995;61:372-73.
23. Palmery M, et al. Further studies of the adrenolytic activity of the major alkaloids from Hydrastis canadensis L. on isolated rabbit aorta. Phytother Res . 1996;10:S47-49.
24. Cometa M, et al. Acute effect of alkaloids from Hydrastis canadensis L. on guinea pig ileum: structure-activity relationships. Phytother Res . 1996;10:S56-58.
25. Baldazzi C, et al. Effects of the major alkaloid of Hydrastis canadensis L., berberine, on rabbit prostate strips. Phytother Res . 1998;12:589-91.
26. Kardos J, et al. Inhibition of [3H] GABA binding to rat brain synaptic membranes by bicuculline related alkaloids. Biochem Pharmacol . 1984;33:3537-45.
27. Claus E, ed. Pharmacognosy . 3rd ed. Philadelphia, PA: Lea & Febiger; 1956.
28. Brinker FJ. Herb Contraindications and Drug Interactions . 2nd ed. Sandy, OR: Eclectic Medical Publications; 1998.
29. Newall CA, Anderson LA, Phillipson JD, eds. Herbal Medicines: A Guide for Health-Care Professionals . London: Pharmaceutical Press; 1996.
30. Ernst E. Herbal medicinal products during pregnancy: are they safe? BJOG . 2002;109:227-235.
31. Sandhu RS, et al. Influence of goldenseal root on the pharmacokinetics of indinavir. J Clin Pharmacol . 2003;43:1283-1288.
![]() |
Link to Page | ![]() |
Print Page | ![]() |
Email Page |









